Trial intelligence / Profile preview

Metronidazole Formulations in CDAD

NCT01559545Phase 2Completed

Sponsor
Dr. Reddy's Laboratories
Start
Mar 2012
Primary completion
Feb 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of metronidazole in Clostridioides difficile infection (CDI), sponsored by Dr. Reddy's Laboratories. Started Mar 2012; status: completed.

02

Drugs

metronidazole
03

Conditions

Clostridioides difficile infection (CDI)

Beyond the preview

Go deeper on NCT01559545.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01559545.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call